Soligenix News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Soligenix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Soligenix Today - Breaking & Trending Today

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection

/PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing. ....

United States , Axel Lehrer , Oreola Donini , Our Public Health Solutions , Us Congress , Exchange Commission , Soligenix Inc , Drug Administration , Defense Threat Reduction Agency , National Institute Of Allergy , Centers For Disease , Biomedical Advanced Research , Prnewswire Soligenix Inc , Development Authority , University Of Hawai , Provides Suvax , Heat Stable Vaccine Seven Years , Exclusivity Upon , Orphan Products Development , Drug Act , Biologics License Application , Senior Vice President , Chief Scientific Officer , Sudan Virus Disease , Sudan Ebola , Generally Regarded ,

Soligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte™ With the European Medicines Agency

/PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing. ....

United States , Biomedical Advanced Research , Exchange Commission , Us Congress , Prnewswire Soligenix Inc , European Medicines Agency , Defense Threat Reduction Agency , Development Authority , Soligenix Inc , Our Public Health Solutions , National Institute Of Allergy , Randomized Study , Continuous Treatment Expected , Extend Results , Statistically Significant Phase , About Hybryte , About Cutaneoust Cell Lymphoma , Public Health Solutions , National Institute , Infectious Diseases , Project Bioshield , Priority Review Voucher ,

Soligenix Announces Formation of Behçet's Disease Medical Advisory Board

/PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing. ....

Hospital For Special Surgery , New York , United States , New York University , Beaumont Hospital , United Kingdom , Johannes Nowatzky , Yusuf Yazici , B Brett Finlay , Christopherj Schaber , Robert Hancock , Andrew Sulich , Saulj Farber , Grossman School Of Medicine , Langone Medical Center , Freie University Berlin , Us Congress , Disease Center , Our Public Health Solutions , Biosplice Therapeutics Inc , Department Of Internal Medicine , Pulmonary Medicine At Instanbul University , Disease Foundation , Drug Administration , Exchange Commission , Soligenix Inc ,

Soligenix to Present at The Microcap Conference

/PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing. ....

Development Authority , Exchange Commission , Us Development , Us Congress , National Institute Of Allergy , Defense Threat Reduction Agency , Biomedical Advanced Research , Prnewswire Soligenix Inc , Soligenix Inc , Our Public Health Solutions , Caesars Atlantic City Hotel , Atlantic City , Microcap Conference , Public Health Solutions , National Institute , Infectious Diseases , Project Bioshield , Priority Review Voucher ,

Soligenix Gets FDA's Fast Track Designation For SGX945 For Oral Lesions Of Behçet's Disease

Soligenix, Inc. (SNGX) announced on Monday that its SGX945 or Dusquetide development program for oral lesions of Behçet's Disease has received a 'Fast Track' designation from the FDA. ....

Soligenix Inc , Fast Track , Stock Alert ,